Combined, these clinical data suggest that, like the animal models, recruitment of WAT-derived stroma promotes cancer progression, and implicate CXCL12 as a cytokine secreted by ASC that contribute to tumor aggressiveness (Fig. 6). Here, CXCL12 is linked to neoplasm.